Galderma (GALD · SIX)

HealthcareSIXEUROPELarge

Advancing dermatology for every skin story

Leading the Dermatology Boom with Premium Brands, Recurring Revenue, and Innovation-Driven Growth

Galderma Group AG

GALD: SIX

161.45 USD

+0.84%

year to date

Market Cap$37.44B

Avg Volume521.22K

Price$161.45+0.56%

P/E Ratio52.38ttm

Pricing delayed 20 minutes Oct 5, 2026, 12:00 AM

Market Leadership in a High-Growth Sector
Strong double-digit growth across Injectable Aesthetics, Skincare, and Therapeutics.
Recurring Revenue & Brand Stickiness
Injectable treatments and skincare loyalty create high-margin, predictable revenue streams.
Breakthrough Innovation Driving Growth
Nemluvio® & Relfydess® are blockbuster potential launches in multi-billion-dollar markets.

Market Sensitivity
Economic downturns may impact aesthetic and discretionary skincare spending.
Regulatory & Competitive Risks
New entrants and shifting regulations could challenge pricing and market access.
Manufacturing & Supply Chain Challenges
Scaling production for biologics and neuromodulators requires significant investment and execution precision.